€ 2,500
Price (+ VAT)
Calendar: Nov 18, 2021 - Nov 20, 2021 (2 Days)
Download Brochure

Your Opportunity

Access to medicines in low- and middle-income countries (LMICs) is a complex challenge and there is no ‘one size fits all solution. It requires deep understanding of the context, actors, economics and operational functions. The payer (global donors, national governments and private out-of-pocket) and procurer (supranational, national and sub-national) environment for LMIC markets is complex, heterogeneous across therapeutic categories, and is also rapidly-changing and evolving. Companies find it increasingly difficult to navigate this environment. Global market access teams have to learn new techniques and skills to understand this multi-stakeholder environment. This course brings together a faculty team with vast and rich experience in the theory and practice of access to medicines helping you to navigate and make decisions within LMIC markets.


While grounded in strong theory, the course will use case studies and practical examples as a pedagogical approach. The high profile of the international experts and the faculty involved in the course will ensure a highly interactive and rewarding learning environment.

Program Agenda
2 days on campus

2 days on campus: 18-20 November 2021 (18 only afternoon, 20 only morning)

What you'll be working on
Expected outcomes
  • Deep understanding of the payer landscape for products with supranational payers (Global Fund, Global Alliance for Vaccines and Immunization (GAVI), Global Financing Facility (GFF), StopTB’s Global Drug Facility (GDF):
  • Deep understanding of the nature of procurement processes and market-shaping strategies used by supranational payers to promote access
  • Deep understanding of the payers for therapeutic categories which are paid for national governments, private insurers and out-of-pocket payments in LMICs
  • Familiarity with the in-country procurement eco-system in LMICs
  • Understanding the architecture of drug and medical device regulation in LMICs, supranational e.g. World Health Organization, Eurasian Conformity Mark vs national Food & Drug Administrations. Also, different groups e.g. Global Harmonization Task Force (GHTF)
  • Designing successful route to market strategies for products in LMICs
  • Modalities for an effective engagement with key market access stakeholders and how to address possible conflicts of interests.
  • Understanding the structure of medicine distribution in LMICs and how it differs from high-income markets
  • Case studies of successful public partnerships to improve distribution reach
  • Innovative distribution models and opportunities to disrupt the distribution market
  • Provide participants with the concepts, tools, terminology and insights that will foster stronger communication with counterparts working in global agencies and LMIC country governments
  • Comprehend the opportunities and pitfalls of using tiered pricing in LMICs
  • Understand health technology assessment, pricing and reimbursement approaches used in LMICs
  • Organizational design for success in LMICs
  • Address project management capacities issues.


Who it is for

The program is designed for global market access managers interested in enhancing their understanding of the complexities surrounding market access in LMICs and engaging with their peers.





"Access to medicines in low and middle income countries requires joint efforts and competencies by a wide range of stakeholders. The course will explore the conditions, tools and techniques that can make the difference. An opportunity to share in an international context and with a global perspective ideas, experiences, solutions...knowledge and passion for public value!"

Go to CV

Monica Otto

"Creative, innovative approaches are needed in assuring essential medicines are manufactured, authorized, and distributed in low- and middle-income countries (LMICs) at affordable conditions. Global market access teams have to learn new techniques and to develop new skills to understand this complex multi-stakeholder environment. This course brings together an extraordinary faculty with vast experience in the theory and practice of access to medicines, a unique opportunity to learn how to navigate and be successful in these emerging markets."

Go to CV

Viviana Mangiaterra

Go to BIO

Brenda Waning
Faculty Member; Chief, Global Drug Facility, Stop TB Parternship at UNOPS

Brenda Waning is the Chief of the Stop TB Partnership’s Global Drug Facility (GDF) – the world’s largest supplier of tuberculosis medicines and diagnostics for the public sector. Waning is a leading expert with more than 20 years of experience in promoting access to medicines in low-resource settings, with a focus on the intersection of pharmaceutical policy, market strategies, and access to medicines. She serves on several expert advisory groups across many different disease and technical areas.


Go to BIO

Prashant Yadav
Faculty Member; Strategy Leader- Supply Chain- Bill & Melinda Gates Foundation; Sr Lecturer at Harvard Medical School

Prashant Yadav is a Sr Lecturer at Harvard Medical School and Strategy Leader-Supply Chain at the Bill & Melinda Gates Foundation. Yadav is globally recognized scholar in healthcare supply chains in frontier markets. His work has also been featured in prominent print and broadcast media such Economist, Financial Times, Nature, and BBC. 

Learn More
Request information



The final deadline for enrollment is 29 October 2021. Enrollment requests are reviewed on a rolling basis, and those received after the final deadline may not be considered.

A 10% reduction on the program fee is offered to applications sent in by 19 September 2021.


Discover the safety standards of our new headquarters


At the end of the program a participation certificate will be issued to the participants (minimun required frequency: 80% of training hours).


Special Payment Terms

Women Are Good For Business and We Need More


To foster women’s education in management and contribute to their professional development, SDA Bocconi School of Management offers them, until 8 March 2022, a 20% reduction on the participation fee for all Executive Open Programs, including Online On Demand. This reduction cannot be combined with other promotional offers.

Bocconi Alumni are entitled to a 30% reduction on participation fees. To take advantage of the discount, please enter your Alumnus status when registering by indicating “ALUMNI30” in the notes section. Remember that without this indication, the discount will not be applicable.
Moreover, 2021 marks the 50th anniversary of SDA Bocconi School of Management. To celebrate this important milestone, we are pleased to offer a gift to our former students: each Alumnus can attend an Executive Open Program for free when a colleague or friend enrolls for the same Program.

Learn more

The two offers are not cumulative.



All those who have taken part in the School's training programs become members, free of charge and with no expiration date, of the #MINE Community.

Learn more



For further information and orientation

Take action
  • Download Brochure

Related Programs

Related Articles

The importance of the team for managing risk and enhancin...
Required time 6 min
Budgeting in healthcare can (and must) change
Required time 5 min
PROs: healthcare seen through the eyes of the patient
Required time 5 min